Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-28 4:46 pm Purchase | 2025-02-06 | 13D | CYCLACEL PHARMACEUTICALS INC C CYCC | Lazar David E. | 162,588 15.840% | 162,588 (New Position) | Filing History |
| 2025-02-14 5:40 pm Purchase | 2024-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | ARMISTICE CAPITAL LLC | 3,507 9.990% | 2,579 (+277.91%) | Filing History |
| 2024-11-14 7:21 pm Sale | 2024-09-30 | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Lind Global Fund II LP | 0 0.000% | -426 (Position Closed) | Filing History |
| 2024-11-14 3:27 pm Purchase | 2024-09-30 | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | ARMISTICE CAPITAL LLC | 928 9.990% | 928 (New Position) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Schonfeld Strategic Advisors LLC | 8 0.180% | -206 (-96.26%) | Filing History |
| 2024-02-14 10:09 am Sale | 2023-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Dellora Investments Master Fund LP | 0 0.000% | -180 (Position Closed) | Filing History |
| 2024-02-13 3:47 pm Unchanged | 2023-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Altium Capital Management LLC | 809 4.990% | 0 (Unchanged) | Filing History |
| 2024-02-07 5:03 pm Sale | 2023-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | ACORN BIOVENTURES, L.P. | 0 0.000% | -782 (Position Closed) | Filing History |
| 2024-01-10 1:35 pm Purchase | 2023-12-21 | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Altium Capital Management LLC | 809 8.000% | 809 (New Position) | Filing History |
| 2024-01-04 4:30 pm Purchase | 2023-12-26 | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Lind Global Fund II LP | 426 9.900% | 426 (New Position) | Filing History |
| 2023-02-14 4:31 pm Purchase | 2022-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Schonfeld Strategic Advisors LLC | 214 6.140% | 214 (New Position) | Filing History |
| 2023-02-13 4:16 pm Unchanged | 2022-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Dellora Investments Master Fund LP | 180 5.200% | 0 (Unchanged) | Filing History |
| 2023-02-06 11:27 am Sale | 2022-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | SPHERA FUNDS MANAGEMENT LTD. | 69 1.990% | -72 (-51.06%) | Filing History |
| 2023-01-26 1:36 pm Purchase | 2022-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | ACORN BIOVENTURES, L.P. | 782 9.990% | 131 (+20.12%) | Filing History |
| 2022-08-22 1:17 pm Purchase | 2022-08-11 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Dellora Investments Master Fund LP | 180 5.200% | 180 (New Position) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Ikarian Capital, LLC | 28 1.000% | -83 (-74.77%) | Filing History |
| 2022-02-14 06:15 am Unchanged | 2021-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | SPHERA FUNDS MANAGEMENT LTD. | 141 5.100% | 0 (Unchanged) | Filing History |
| 2022-02-04 4:03 pm Unchanged | 2021-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Hudson Bay Capital Management LP | 115 3.970% | 0 (Unchanged) | Filing History |